Lionheart Health, Inc., a company specializing in bioelectric regenerative medicine and healthspan optimization technologies, has appointed Dr. Joseph C. Maroon to its Scientific and Clinical Advisory Board. Dr. Maroon is a board-certified neurosurgeon and Clinical Professor of Neurosurgery at the University of Pittsburgh Medical Center (UPMC) with decades of experience as Team Neurosurgeon for the Pittsburgh Steelers. His expertise spans brain health, sports neurosurgery, concussion management, neuroinflammation, and longevity science.
The appointment reinforces Lionheart Health's commitment to developing evidence-based bioelectric stimulation therapies designed to improve cognition, memory, and mood while supporting neuroplasticity and reducing systemic inflammation. Dr. Maroon's background in preventive neurology and functional medicine aligns with the company's focus on measurable improvements in muscle, brain, and immune function. He has authored best-selling books including Square One, which emphasizes foundational strategies for optimizing long-term brain and body health.
Dr. Maroon will advise on multiple clinical initiatives, including brain health study design, neurocognitive endpoint validation, and applications for concussion and neuroinflammation. He will also help translate regenerative signaling science into clinical protocols and integrate lifestyle, supplementation, and bioelectric strategies for healthspan extension. "Optimizing brain health is central to extending meaningful healthspan," Dr. Maroon commented regarding his new role. "I look forward to supporting Lionheart Health's efforts to scientifically validate innovative bioelectric therapies that aim to improve neurological resilience, reduce inflammation, and enhance overall vitality."
Lionheart Health's technology platform includes patented bioelectric stimulation systems such as BodStim™ and Brain Band™, which target key regenerative and neuroprotective signaling pathways including Klotho, Brain-Derived Neurotrophic Factor (BDNF), GDF10, SDF-1, PDGF, and eNOS. These pathways are recognized for their roles in neuroplasticity, synaptic resilience, angiogenesis, stem cell homing, endothelial health, and inflammation modulation. The company's brain health initiatives represent one of three core pillars in its participation in the $101M XPRIZE Healthspan Competition.
The company has received significant recognition for its technological advancements. Brain Band™ recently received a UCI Capstone Grant, providing a multidisciplinary team of five University of California, Irvine engineering PhD-level researchers who worked over seven months to advance device optimization and signal validation. Medtech Outlook Magazine recognized Lionheart Health as 2025 Micro Stimulator Developer of the Year. The company also won the Abbvie Allergan ULP Innovation Award and was a finalist in both the Orange County Business Journal's Innovator of Year Awards and Octane's Life Sciences Technology Company of Year Award in 2025.
Lionheart Health has completed successful pre-clinical studies at AccuLab Life Sciences in San Diego with grant and credit line support, as well as a successful pilot clinical study in Brazil. The company is preparing to enroll participants in a combination BodStim™ bioelectric stimulation exercise suit and Brain Band™ clinical trial for brain health, building on previous studies that separately demonstrated statistically significant improvements in brain health outcomes. More information about the company's technologies and research can be found at https://www.LionheartLongevity.com and https://www.LionheartHealthstim.com.
Dr. Maroon brings more than four decades of leadership in academic neurosurgery, clinical innovation, and performance medicine to his advisory role. He has performed thousands of complex brain and spine procedures and is internationally recognized for advancing minimally invasive neurosurgical techniques. His research contributions include more than 300 peer-reviewed publications and multiple textbooks in neurosurgery, inflammation science, and sports medicine, with particular focus on neuroinflammation, omega-3 fatty acids in brain protection, and integrative strategies for preserving cognitive function across the lifespan.
The collaboration between Dr. Maroon's clinical expertise and Lionheart Health's technological platform represents a significant development in the field of healthspan optimization. By combining neurosurgical knowledge with bioelectric stimulation technologies, the partnership aims to address critical aspects of aging, particularly cognitive decline and neuroinflammation. This approach could potentially influence clinical practices in neurology, sports medicine, and preventive healthcare, offering non-invasive alternatives for maintaining brain function and extending healthy years of life.
